Magazine Publishing Businesses Seeking Loan in Syracuse

The business is currently working with 30 suppliers (breweries) and we have an extensive online marketplace. We take a supplying brewery's brand under our brand portfolio and then distribute their products. Unfortunately, suppliers are being turned away at this time until we can achieve scale. Interest in our unique service is extensive.

Clients: currently, we have 5 clients. - Our business specialized in developing diagnostics and therapeutics for human basal cell carcinoma, squamous cell carcinoma, and melanoma. This skin cancer group comprises the most diagnosed cancers worldwide of all cancer types with over five million cases diagnosed each year. - The skin cancer therapeutics diagnostics and therapeutics products industry worldwide were worth $8.2 billion USD in 2019 and is projected to reach $15 billion by 2027. This represents a CAGR of 7.5%. - What share of the total skin cancer target market is realistic for us to obtain? A conservative estimate is that our company should be able to reach $200 million USD in annual revenues by the close of 2028. Problem or Need: - The main project involves the development of a Skin Cancer Patient Data Blockchain. - Currently there is a serious problem concerning how oncology patients organize and share their medical data, how companies get access to this data, and a lack of return in value to the patients for sharing their personal data. The blockchain is designed to tackle and solve these problems. - The blockchain for skin cancer patients will be comprised of multiple decentralized nodes contributing data to a shared ledger where patients can set up smart contracts to share and control their data. - Skin cancer patients will be able to share their data with research institutions, drug companies, diagnostic companies, contract research organizations, client trials organizers, and other stakeholders. - Also, planning to launch a medium of exchange within the blockchain system to allow patients to be given money for participation in the sharing of their data with the mentioned company stakeholders. - Therefore, the company stakeholders that plan to utilize the patient’s data would provide revenues and income to support the operations of the blockchain. - For example, pharmaceutical companies would be important customers that the business would cultivate as users of the patient’s healthcare data. This is because pharma companies can use this blockchain to discover patients with the right profile for a skin cancer clinical trial, even if those patients were not actively searching to participate in a clinical trial for a product from which the pharma or diagnostics company might benefit. This should greatly streamline for the pharma company the time it takes to enroll the right patients into clinical trials and get them started. Value Proposition: Solution: - What is the core value proposition? For the company stakeholders in the skin cancer patient blockchain, the business is hoping to demonstrate that this blockchain technology will be a way to improve business outcomes through better efficiency, risk management, and security. - For these customers, this will enable them to maintain and capture new sources of profit. At the same time, company stakeholder participation will also grow the business as the integrator and host of the blockchain and result in significant profit growth for the company. Team: The team is comprised of: - Founder, President, and CEO, a 100% full-time permanent employee has a Ph. D. in Cell and Molecular Biology from St. John’s University (New York, NY), a M. S. in Microbiology & Immunology from Long Island University, and a M. B. A. from Le Moyne College. In addition, he has 20 years of quality assurance and regulatory affairs experience at the Bristol-Myers Squibb Company, Charles Rivers Laboratories, and Vybion, Inc. This includes moving numerous human therapeutic products from R&D, through clinical trials, and into the marketplace via approval by the US FDA and worldwide regulatory bodies. In addition to the above experience, Joseph has an addition 18 year of experience in human therapeutics research and development and in the management of laboratory-based cell culture, toxicological, or bioassay projects within the biopharmaceuticals industry. He is also a Senior Member of the food, drugs & cosmetics section of the American Society for Quality (ASQ), and a society member of The American Association for the Advancement of Science (AAAS). - The President of Hillberg Consulting is a part-time, non-permanent hourly contract employee of R&D department. She is an accomplished executive and board member with a reputation for delivering bottom-line profitability while building the infrastructure to support growth and success. She has served at Johnson & Johnson Ortho Clinical Diagnostics as VP of R&D, and as Chief Technology Officer at Carestream Health. Holly has a B. S. in Chemical Engineering from Michigan Technology University and a M. S. in Electrical Engineering from Rochester Institute of Technology. - Marketing Consultant - part-time, non-permanent hourly employee. He is a professional engineer and entrepreneurial executive with a focus on emerging technology solutions applied to real world problems. He has substantial experience in team building and in developing market strategies & partnerships. This includes over two decades of technology & networks business planning, development, & implementation. He has a Masters in Entrepreneurial Studies - MIT Sloan School of Management, and M. S. & B. S. in Engineering from Syracuse U. and Utica College. - Blockchain Development Technical Project Management Consultant - Part-time, non-permanent hourly employee that is a contractor from EffectiveSoft Corporation, San Diego, CA. She has eight years of experience as VP of Service Delivery and as the Head of Sales for enterprise level software solutions at Effective Soft Corp. She has a M. B. A. from The University of Manchester and a B. S. degree from Minsk State Linguistics U. – Legal Counsel - Part-time, non-permanent hourly contract employee. He holds the Juris Doctor from Boston College Law School, and B. A. in Political Science from Binghamton University. He is a Partner at Newman & Lickstein, with eight years of experience in representing technology companies and investors in licensing, IP development, real estate, mergers & acquisitions, and business litigation. -Medical Advisor - He is a board-certified dermatologist and fellowship-trained dermatologic surgeon from Northwestern University in Chicago that also has conducted translational research on skin, melanocytes, and photobiology, and the effects of natural compounds on skin. - Demonstrating results to stakeholders will be the key to success. For skin cancer, there is a lot of data collected from various heterogeneous sources – pathology imaging data, genetic testing, surgery, drugs intervention, payer, and insurance information, etc. - Some companies are using a website or app to meet the social needs of patients to discuss their concerns with other patients or a few qualified physicians. No competitor is comprehensively focusing on skin cancer data & treatment to the level that we do. Possible competitors have thus not yet integrated the patient data, shared consent, and the patient monetization blocks together into a comprehensive and workable blockchain system for skin cancer patients, or for any segment of the oncology market, for that matter. - This team, on the other hand, has decades of experience in oncology research, the development of products and services for cancer patients, in oncology clinical biomedicine and in oncology marketing, and that makes the company well-equipped to solve the problems around skin cancer patient data acquisition, its organization, and its beneficial use for the patients and for their healthcare providers. For example, regarding the latter, the company also harnesses artificial intelligence (AI) and machine learning (ML) to extract relevant data from the patient’s database that will help healthcare providers to better understand the patient’s tumor and the tumor microenvironment (i. e. , tumor growth, cellular migration, blood supply to the tumor, subcellular trafficking, and tumor metastasis), drug efficacy (including drug penetration into the tumor, possible tumor shrinkage or tumor death, and drug toxicity, and side effects), or the immediate or long term results of surgical intervention. - When competitors enter this specific market, the business plans to stand out by utilizing a value-based strategy that clearly displays our brand and the above competitive advantage. • Traction: - Currently works with pharmaceutical and diagnostic companies, research institutes, and contract research development and manufacturing companies to help them obtain and organize their molecular bioassays and pathology data. We propose to utilize this traction and intercompany personal connections to gain and grow customers that will use and pay for patient data on the blockchain. - Also use social media & patient advocacy organization to recommend the blockchain to skin cancer patients so that we can grow the patient database. - The company is also a member of the Hyperledger Foundation Healthcare Special Interest Group. Hyperledger, as part of the Linux Foundation, provides technology leaders with a uniquely open and collaborative international community from which to develop, validate, and field enterprise-grade blockchain technology solutions. It is the mandate of the Hyperledger Healthcare Special Interest Group (HC-SIG) to represent healthcare professionals and technologists, to globally unite these individuals, and to advance the state of the healthcare industry through the implementation of technology solutions using blockchain technologies in general, and the umbrella of Hyperledger frameworks and toolsets specifically. • Revenue Model: - Within the ecosystem surrounding the above patients, who would buy/lease the skin cancer blockchain services that the company wishes to market? In this blockchain system, individuals will be allowed to store and monetize their own health data including blood test results, medical history, genetic profile, skin photographs, pathology images and other sensitive information. - In the healthcare marketplace, cancer patients would be paid in stablecoin currency to lease their individual data to companies for a certain amount of time. - Pharmaceutical (pharma) companies would be important customers that the company would cultivate as users of the patient’s permitted healthcare data. - Blockchain can help pharma companies discover patients with the right profile for a clinical trial, even if those patients were not actively searching to participate in a clinical trial for a product from which the pharma or diagnostics company might benefit. - According to Milind Kamkolkar, chief data officer at Sanofi, patients could be prompted based on their data to join a clinical trial, thereby also accelerating the process and accuracy of trial recruitment. Using this blockchain if a person declines, no personal information will be shared, and the person's identity will remain private. If the person agrees, the overall process will move faster by abolishing the need for intermediaries. - For pharma companies, better inclusion in clinical trials and better reproducibility for studies can reduce the time and money needed to develop new drugs. - Besides pharma companies, research institutes will be willing to pay for the data from skin cancer patients, and the introduction of our blockchain-based data ecosystem may help ensure that the individuals take control over their data and companies and research institutions may acquire data more freely after the latter have obtained consent from individual patients. - How are the products and services going to generate revenue? The most straightforward way to generate revenue is to have the blockchain client customers pay for the products and services that exceed by a large margin what it costs to develop and operate the blockchain (a cost-plus strategy). - When competitors enter this specific market, plan to stand out by utilizing a value-based strategy that clearly displays the brand and competitive advantage. • Market Projections: - What share of the total skin cancer blockchain target market can we estimate is realistic for to obtain? The global skin cancer blockchain customer market size stood at USD 8.19 billion in 2019 and is projected to reach USD 14.55 billion by 2027, exhibiting a CAGR of 7.5% during the forecast period. A conservative estimate is that the company should be able to reach $150 million in annual revenues in 4 years. - These financial projections would be possible because of the company participating and partnering with individuals and companies within the oncology community to create superior value for the products and services. - Over the next 4 years, the company anticipates receiving funding from investors, and revenues from pharmaceutical companies and research institute customers. - However, expenditure are also expected to increase. Expenses incurred will be for the development of products and services, and for personnel, equipment, supplies, business development & marketing. • Competition: - We have identified Nebula Genomics and Longenesis as competitors. These two leading firms in artificial intelligence and blockchain technology for healthcare, are developing a platform for the storage and exchange of genomic data. - Nebula Genomics is a San Francisco-based biotechnical company that uses blockchain to “build a marketplace” for clinical genetics data. - Longenesis is a Hong Kong-based partnership between Insilico Medicine and the Bitfury Group, which makes blockchain platforms for the exchange of health data. - The above companies will reportedly apply artificial intelligence and blockchain technology to develop a platform for individuals and large data providers to store, manage, exchange, and profit from genomic and other types of clinical data. To automate data acquisition, the project developed by both Nebula Genomics and Longenesis will utilize smart contracts. - Unlike the Nebula Genomics and Longenesis blockchains, this blockchain project will be focused on oncology patients and the ecosystem around them rather than on a multitude of disease sectors. - In addition to Nebula Genomics and Longenesis, the U. S. -based life science research marketplace, Scientist. com, has revealed the development of a pharmaceuticals blockchain platform. This latter blockchain-powered platform is reportedly designed to track and protect pharmaceutical data. Thus, the Scientist. com DataSmart TM platform enables pharmaceutical and biotech companies to demonstrate that critical supplier information and important research data has not been tampered with and remains unaltered before submission to regulators such as the FDA and the EMEA. - However, the above platforms do not adequately address the pressing concerns of cancer patients regarding the control and sharing of their personal data. Competitive Advantage: • Strategy. Specifically for oncology blockchain products, the major company players that may join our blockchain to gain access to data from skin cancer patients include: Almirall S. A. Amgen, Inc. Boehringer Ingelheim GmbH. Bristol-Myers Squibb Company. Eli Lilly and Company. Elekta AB. F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc. Merck & Co. , Inc. Mylan NV. Novartis AG. Pfizer. Regeneron. Sanofi. Sun Pharmaceutical Industries Ltd. Varian Medical Systems, Inc. Sensus Healthcare. ICAD, Inc. Accuray, Inc.

Westbury-based global consulting specializing in public housing and infrastructure development attracts international clients and partners. - Strong global presence with clients across Jamaica, Trinidad & Tobago, Namibia, Italy, and Brazil, working with private investors and government entities. - Expertise in brokering collaboration among investors, developers, and governments, facilitating successful housing project developments on an international scale. - Diverse revenue streams include project development fees, equity in projects, investment facilitation, and consulting fees, ensuring stable and aligned financial interests. - Established partnerships with leading financial entities to enhance project success and market reach. - Despite a compact team of only two employees, the firm manages substantial projects backed by robust alliances and strategic collaborations. - Serving seven major clients, the firm leverages its specialized consulting services to drive global economic growth initiatives and infrastructure development.

Westbury-based global consulting specializing in public housing and infrastructure development attracts international clients and partners. - Strong global presence with clients across Jamaica, Trinidad & Tobago, Namibia, Italy, and Brazil, working with private investors and government entities. - Expertise in brokering collaboration among investors, developers, and governments, facilitating successful housing project developments on an international scale. - Diverse revenue streams include project development fees, equity in projects, investment facilitation, and consulting fees, ensuring stable and aligned financial interests. - Established partnerships with leading financial entities to enhance project success and market reach. - Despite a compact team of only two employees, the firm manages substantial projects backed by robust alliances and strategic collaborations. - Serving seven major clients, the firm leverages its specialized consulting services to drive global economic growth initiatives and infrastructure development.

We have experienced incredible growth and been received quite positively so far. The promoter is a classical archaeologist, art historian, and professor who has been living and teaching in Rome for 20 years, always with a passion for jewelry. The other partner grew up in Italy and is an artist. We started very small, with word of mouth and limited advertising, but the feedback has been outstanding. We are ready to take the business to the next level.

Located in Buffalo, the company operates within the niche of air purification and industrial filters, catering to a variety of environments including hospitals, clean rooms, and paint booths. - The business manufactures cutting-edge air purification systems and distributes high-quality air filters, ensuring optimal air quality in industrial and specialized settings. - Employing 21 skilled professionals, the business is well-positioned to deliver tailored air filtration solutions that meet complex client needs. - Boasts a robust customer base of 1,200 longtime clients, contributing to 60% of its revenue through recurring filter sales post-installation, underscoring a highly sustainable business model. - The recurring revenue stream is significantly bolstered by maintenance and advisory services that facilitate ongoing engagement and repeat purchases from satisfied clients. - Establishes and nurtures long-term partnerships by offering expert advice on the integration of new air purification solutions with evolving customer processes. - The business serves as both a manufacturer and distributor, providing end-to-end solutions in the air filtration industry, thus giving it a competitive edge in maintaining and growing its market presence.

Established eCommerce store specializing in health and beauty products, operational for 3 years, with a proven track record of generating over USD 1 million in revenue. - Diverse product range featuring top-selling categories: skincare, haircare, and healthcare products, catering to evolving consumer trends. - Strong supplier relationships facilitate a commission structure of 30-60% on sales, maximizing profitability. - Daily website traffic of over 15,000 visitors, demonstrating a solid base of potential customers and engagement. - Predominantly servicing the USA, the business effectively capitalizes on a lucrative domestic market for beauty and wellness. - Operated by a single employee, showcasing the potential for scalability and streamlined operational management. - Recent marketing strategies have slightly impacted sales, indicating opportunities for targeted reinvestment and growth potential. - The company is registered in the USA, with the promoter operating from Israel.

Established pharmacy retail in New York City. - Handles an impressive volume of 150-200 prescriptions daily, translating to over 50,000 prescriptions annually. - Consistent monthly revenue of approximately $50,000, demonstrating stable financial performance. - Offers specialized compounding services for dermatology patients, enhancing service differentiation. - Licensed by the U. S. State Board of Pharmacy and possesses necessary drug licenses, ensuring compliance and credibility. - Outsourced logistics and flexible employment strategy with temporary staff hired on demand in addition to 6 permanent employees.

A family-owned and operated mobile welding service based in New York, with over 40 years of industry experience. - The company serves clients in the Tri-State Area, catering primarily to commercial clients. - On average, the business serves 15-20 clients per month. - The average service charges range between USD 600-800. - The business is AWS Certified. - Business is primarily operated by the owner, with additional temporary employees brought on an as-needed basis to meet demand. - There has been a reduction in sales this year as compared to last year because of the drop in client base.

The tavern attracts a significant customer traffic. - Average order value is USD 50-60. - The business also boasts an outdoor patio, a 30-seat square bar with breathtaking lake views. - Has a scenic view of the lake from the inside and docks outside for boaters. - The tavern holds a liquor license, allowing for the sale of alcoholic beverages. - The business has completed health department inspections. - There are 4 permanent employees who are sufficient to manage the business operations, no additional contract/temporary employees required.

Company Overview: We are a unique fried chicken and waffles restaurant, pioneering a niche yet rapidly growing segment in the culinary world. Our establishment brings together the comforting, savory flavors of perfectly fried chicken with the delightful variety of flavor infused waffles, creating a one-of-a-kind dining experience that appeals to diverse palates. Vision: Our vision is to become the undisputed leader in the global Halal fried chicken and waffle sandwiches industry. We aim to be renowned for our unparalleled taste, exceptional service, and unwavering commitment to culinary innovation, coupled with tech and AI-driven operations. Mission: We are dedicated to crafting memorable moments for our customers, fostering a sense of community, and setting the standard for excellence in the industry. Every meal served is a testament to our dedication to quality, flavor, and customer satisfaction. Promoters: Our team of promoters consists of seasoned restaurateurs and culinary innovators with extensive experience in the food and beverage industry. They bring a wealth of knowledge and passion for creating unique, high-quality dining experiences. Their expertise in business development, marketing, and operations ensures that our brand remains competitive and forward-thinking. Business Model: Our business model is designed to maximize profitability while maintaining a strong focus on quality and customer satisfaction. Key components include: - Franchise Model: We offer franchise opportunities that provide comprehensive support, including site selection, training, marketing, and ongoing operational assistance. - Menu Innovation: Regularly updated menu items to keep customers excited and engaged. - Local Sourcing: Whenever possible, we source ingredients locally to ensure freshness and support local economies. - Technology Integration: Utilizing modern technology for efficient operations, including online ordering, delivery partnerships, and a robust customer loyalty program. Average Footfall Per Outlet: Our outlets typically attract a strong and steady footfall, with an average of 500-700 customers per week. This consistent traffic is driven by our unique menu offerings, high standards of service, and strategic location selections. Competitive Differentiation: What sets us apart from the competition includes? - Unique Offering: We are one of the few brands specializing in Halal fried chicken and waffle sandwiches, catering to a niche market with high demand. - Quality and Taste: Our recipes are meticulously crafted to deliver an unforgettable taste experience, using only the finest ingredients. - Customer Experience: We prioritize creating a welcoming and enjoyable atmosphere, ensuring every customer leaves satisfied. - Community Engagement: We actively engage with our local communities through events, sponsorships, and collaborations, building strong, loyal customer bases. Why Invest in Our Brand? - Proven Concept: Our unique fusion of fried chicken and waffles has already demonstrated strong market appeal and profitability. - Growing Market: The demand for Halal dining options is increasing globally, providing significant growth opportunities. - Support System: Investors receive extensive support, from initial training to ongoing operational assistance, ensuring a smooth and successful franchise experience. - Brand Strength: Our brand is synonymous with quality and innovation, which helps attract and retain a loyal customer base. - Scalability: Our business model is designed for easy replication and scalability, allowing for efficient expansion into new markets. Investing in our brand means joining a forward-thinking, innovative company with a clear vision and a solid foundation for future growth. We invite you to be part of our journey to become the leading name in the Halal fried chicken and waffle sandwich industry.

We are a travel centre/truck stop startup business. - We provide various services in our centres. - The business already has 5 centres so far and is looking for investment for a new project. - This is a state-of-the-art travel centre to be built on a 43-acre parcel that has 45 car parking and 80 truck parking spaces with two national tenants. - The project details can be discussed over the phone or email.

Franchise Ready is a specialist franchise consulting business that has been twice awarded the best franchise consulting firm in the world. We have launched over 200 brands into franchising, developing all the assets, resources, systems and strategic work needed to grow a brand globally through franchising. Once we get our brands ready we take them to market and find master franchise partners and unit franchisees for our clients. We are a one stop shop for everything you need related to franchising.